Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...
Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
This article was reviewed by Darragh O’Carroll, MD. Understanding Blood Tests: How They Work and What They Can Tell You Blood ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback